Fludarabine, Cyclophosphamide, Ofatumumab (FC-O2) As Front-Line Treatment for Young and Fit Patients with Chronic Lymphocytic Leukemia (CLL): Preliminary Results of the Prospective Phase 2 LLC0911 Gimema Study
2015-01-01 Mauro, Fr; Zaja, F; Molica, S; Coscia, Marta; Liberati, Am; Piciocchri, A; Ilariucci, F; Russo, F; Re, F; Tedeschi, A; Baraldi, A; Carella, Am; Gozzetti, A; Del Poeta, G; Cortelezzi, A; Battistini, R; Iannella, E; Ferretti, A; Del Giudice, I; Della Starza, I; Raponi, S; De Propris, Ms; Ilari, C; Cafforio, L; Nanni, M; Fazi, P; Vignetti, M; Neri, A; Specchia, G; Cuneo, A; Guarini, A; Foa, R.
Effective anti-tumor immunomodulatory properties of zoledronic acid in Balb/c mice transgenic for the her-2/Neu oncogene
2006-01-01 Coscia, Marta; Quaglino, Elena; Pantaleoni, Francesca; Curcio, C; Boccadoro, Mario; Forni, Guido; Massaia, Massimo
A PHASE II MULTI-CENTER TRIAL OF PENTOSTATIN PLUS CYCLOPHOSPHAMIDE WITH OFATUMUMAB (PCO) IN OLDER PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS
2014-01-01 Montillo, M; Rossi, D; Motta, M; Quaresmini, G; Rossi, M; Coscia, Marta; Anastasia, A; Rossini, F; Cortellezzi, A; Nador, G; Scarfo, L; Cairoli, R; Frustaci, Am; Dal Ceggio, D; Picardi, P; De Paoli, L; Orlandi, E; Rambaldi, A; Morra, E; Massaia, Massimo; Tedeschi, A.
ROLE OF THE MEVALONATE PATHWAY IN THE IMMUNOMODULATORY ACTIVITY OF ZOLEDRONIC ACID
2004-01-01 Pantaleoni, F; Mariani, S; Muraro, M; Peola, S; Nuschak, B; Foglietta, M; Castella, B; Fiore, F; Coscia, M; Boccadoro, M; Massaia, M
CD73-generated extracellular adenosine creates microenvironmental conditions favoring growth and survival of chronic lymphocytic leukemia cells
2011-01-01 Serra, Sara; Horenstein, Alberto; Vaisitti, Tiziana; Brusa, Davide; Davide, Rossi; Luca, Laurenti; Giovanni, D'Arena; Coscia, Marta; Claudio, Tripodo; Inghirami, Giorgio; Simon, Robson; Gianluca, Gaidano; Malavasi, Fabio; Deaglio, Silvia
The PD-1/PD-L1 axis contributes to T cell dysfunction in chronic lymphocytic leukemia
2012-01-01 Brusa, Davide; Serra, Sara; Bianco, M; Coscia, Marta; Rossi, D; Gaidano, G; Fedele, G; Deaglio, Silvia
SELINEXOR (KPT-330) IN COMBINATION WITH CHEMOTHERAPY OR IDELALISIB ELICITS A SYNERGISTIC CYTOTOXIC EFFECT IN PRIMARY CLL CELLS, ALSO OVERCOMING INTRINSIC AND STROMAL CELLS-MEDIATED FLUDARABINE RESISTANCE
2018-01-01 Todaro, M; Griggio, V; Vitale, C; Salvetti, C; Riganti, C; Boccadoro, M; Coscia, M
AUTOIMMUNE HAEMOLYTIC ANAEMIA DURING BENDAMUSTINE PLUS RITUXIMAB TREATMENT IN CLL PATIENTS
2015-01-01 Laurenti, L; Autore, F; Innocenti, I; D'Arena, G; Coscia, Marta; Mondello, P; Bellesi, S; Efremov, D; Sica, S; Mauro, Fr
AUTOIMMUNE HAEMOLYTIC ANAEMIA DURING BENDAMUSTINE TREATMENT IN CLL PATIENTS
2015-01-01 Autore, F; Innocenti, I; D'Arena, G; Coscia, Marta; Mondello, P; Pasquale, R; Sica, S; Laurenti, L.
Chlorambucil PLUS Rituximab As FRONT-LINE Therapy for Elderly and/or Unfit CLL Patients. LONG-TERM Follow-up and Correlation with Biologic-Based Risk Stratification
2016-01-01 Laurenti, L; Innocenti, I; Autore, F; Pasquale, R; Vannata, B; Ciolli, S; Mauro, Fr; Mannina, D; Del Poeta, G; D'Arena, G; Massaia, Massimo; Coscia, Marta; Molica, S; Pozzato, G; Efremov, Dg; Marasca, R; Galieni, P; Cuneo, A; Orlando, S; Piciocchi, A; Boncompagni, R; Vincelli, Di; Liberati, Am; Russo, F; Foa, R.
Effective anti-tumor immunomodulatory properties of zoledronic acid
2007-01-01 Coscia, Marta; Quaglino, Elena; Pantaleoni, Francesca; Curcio, C; Rigoni, MICOL MARIA; Forni, Guido; Massaia, Massimo
Selinexor in Combination with Chemotherapy or Idelalisib Elicits a Synergistic Cytotoxic Effect in Primary CLL Cells, Also Overcoming Intrinsic and Stromal Cells-Mediated Fludarabine Resistance
2016-01-01 Todaro, Maria; Griggio, Valentina; Vitale, Candida; Salvetti, Chiara; Riganti, Chiara; Boccadoro, Mario; Landesman, Y; Coscia, Marta
CD200 INCLUDED IN A 4-MARKER MODIFIED MATUTES SCORE PROVIDES OPTIMAL SENSITIVITYAND SPECIFICITY FOR THE DIAGNOSIS OF CHRONIC LYMPHOCYTIC LEUKEMIA
2018-01-01 D'Arena, G; Vitale, C; Rossi, G; Coscia, M; Omede, P; D'Auria, F; Statuto, T; Valvano, L; Ciolli, S; Gilestro, M; Molica, S; Bellesi, S; Topini, G; Panichi, V; Autore, F; Innocenti, I; Musto, P; Deaglio, S; Laurenti, L; Del Vecchio, L
FIRST-LINE TREATMENT CHOICE FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: WHAT DO CLINICIANS CARE ABOUT? THE CLL FITNESS STUDY
2014-01-01 Scarfo, L; Quaresmini, G; Ambrosetti, A; Laurenti, L; Rossini, F; Trentin, L; Coscia, Marta; Orlandi, E; Mannina, D; Torreggiani, A; Rambaldi, A; Semenzato, G; Innocenti, I; Brugiatelli, M; Cuneo, A; Foa, R; Molica, S; Morra, E; Pane, F; Pizzolo, G; Ghia, P.
PROGRESSIVE TELOMERE SHORTENING DURING THE NATURAL HISTORY OF CHRONIC LYMPHOCYTIC LEUKEMIA
2011-01-01 Genuardi, Elisa; Rossi, D; Bernocco, Elisa; Bodoni, Cl; Drandi, Daniela; Coscia, Marta; Ruggeri, Marina; Fangazio, M; Ghione, Paola; Gattei, V; Boccadoro, Mario; Omede', Pierluigi; Massaia, Massimo; Gaidano, G; Ladetto, Marco
The Hypoxia-Inducible Factor-1 alpha Is Constitutively Upregulated in TP53 Disrupted CLL Cells: A Potential Target to Overcome Fludarabine Resistance
2015-01-01 Griggio, Valentina; Vitale, Candida; Riganti, Chiara; Kopecka, Joanna; DAL BO', Moreno; Rossi, D; Pozzato, G; Laurenti, L; Zallio, F; Marchetti, M; Ruggeri, Marina; Omede', Pierluigi; Del Poeta, G; Gattei, V; Gaidano, G; Boccadoro, Mario; Massaia, Massimo; Coscia, Marta
Outcome of Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) and/or 17p Deletion/TP53 Mutations Treated with Ibrutinib According to a Named Patient Program (NPP) in Italy: Preliminary Analysis of a Real Life Retrospective Study
2016-01-01 Mauro, Fr; Tedeschi, A; Piciocchi, A; Motta, M; Iannella, E; Farina, L; Scarfo, L; Marasca, R; Coscia, Marta; Cortelezzi, A; Laurenti, L; Melpignano, A; Zinzani, Pl; Molica, S; Re, F; Andriani, A; Vincelli, Di; Visco, C; Gozzetti, A; Orlandi, Em; Trentin, L; Tani, M; Califano, C; Tagariello, G; Ghia, P; Caputo, Md; Salaroli, A; Innocenti, I; Frustaci, A; Vitale, Candida; Petulla, M; de Fabritiis, P; Vignetti, M; Fazi, P; Foa, R.
EFFICACY AND SAFETY OF CHLORAMBUCIL PLUS RITUXIMAB AS FRONT-LINE THERAPY IN ELDERLY AND/OR UNFIT PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA. A GIMEMA RETROSPECTIVE STUDY
2015-01-01 Laurenti, L; Autore, F; Innocenti, I; Vannata, B; Ciolli, S; Mauro, Fr; Mannina, D; Del Poeta, G; D'Arena, G; Massaia, Massimo; Coscia, Marta; Molica, S; Pozzato, G; Marasca, R; Galieni, P; Cuneo, A; Orlando, S; Piciocchi, A; Boncompagni, R; Vincelli, D; Liberati, Am; Russo, F; Foa, R.
REGULATION OF HIF-1 alpha IN TP53 DISRUPTED CHRONIC LYMPHOCYTIC LEUKEMIA CELLS AND ITS POTENTIAL ROLE AS A THERAPEUTIC TARGET
2018-01-01 Griggio, V; Vitale, C; Todaro, M; Riganti, C; Kopecka, J; Salvetti, C; Bomben, R; DAL BO', Moreno; Rossi, D; Pozzato, G; Marchetti, M; Omede, P; Bonello, L; Kodipad, Aa; Laurenti, GUIDO LUCA ALBINO; Del Poeta, G; Mauro, Fr; Bernardi, R; Gattei, V; Gaidano, G; Foa, R; Massaia, M; Boccadoro, M; Coscia, M
Extracellular Nicotinamide Phosphoribosyltransferase (NAMPT) Shapes the CLL Microenvironment Promoting Macrophage M2 Polarization Via a Non-Enzymatic Mechanism
2014-01-01 Audrito, Valentina; Serra, Sara; Brusa, Davide; Mazzola, F; Arruga, Francesca; Vaisitti, Tiziana; Coscia, Marta; Maffei, Riccardo; Rossi, D; Wang, T; Inghirami, G; Rizzi, M; Gaidano, G; Wolberger, C; Raffaelli, N; Deaglio, Silvia
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Fludarabine, Cyclophosphamide, Ofatumumab (FC-O2) As Front-Line Treatment for Young and Fit Patients with Chronic Lymphocytic Leukemia (CLL): Preliminary Results of the Prospective Phase 2 LLC0911 Gimema Study | 1-gen-2015 | Mauro, Fr; Zaja, F; Molica, S; Coscia, Marta; Liberati, Am; Piciocchri, A; Ilariucci, F; Russo, F; Re, F; Tedeschi, A; Baraldi, A; Carella, Am; Gozzetti, A; Del Poeta, G; Cortelezzi, A; Battistini, R; Iannella, E; Ferretti, A; Del Giudice, I; Della Starza, I; Raponi, S; De Propris, Ms; Ilari, C; Cafforio, L; Nanni, M; Fazi, P; Vignetti, M; Neri, A; Specchia, G; Cuneo, A; Guarini, A; Foa, R. | |
| Effective anti-tumor immunomodulatory properties of zoledronic acid in Balb/c mice transgenic for the her-2/Neu oncogene | 1-gen-2006 | Coscia, Marta; Quaglino, Elena; Pantaleoni, Francesca; Curcio, C; Boccadoro, Mario; Forni, Guido; Massaia, Massimo | |
| A PHASE II MULTI-CENTER TRIAL OF PENTOSTATIN PLUS CYCLOPHOSPHAMIDE WITH OFATUMUMAB (PCO) IN OLDER PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS | 1-gen-2014 | Montillo, M; Rossi, D; Motta, M; Quaresmini, G; Rossi, M; Coscia, Marta; Anastasia, A; Rossini, F; Cortellezzi, A; Nador, G; Scarfo, L; Cairoli, R; Frustaci, Am; Dal Ceggio, D; Picardi, P; De Paoli, L; Orlandi, E; Rambaldi, A; Morra, E; Massaia, Massimo; Tedeschi, A. | |
| ROLE OF THE MEVALONATE PATHWAY IN THE IMMUNOMODULATORY ACTIVITY OF ZOLEDRONIC ACID | 1-gen-2004 | Pantaleoni, F; Mariani, S; Muraro, M; Peola, S; Nuschak, B; Foglietta, M; Castella, B; Fiore, F; Coscia, M; Boccadoro, M; Massaia, M | |
| CD73-generated extracellular adenosine creates microenvironmental conditions favoring growth and survival of chronic lymphocytic leukemia cells | 1-gen-2011 | Serra, Sara; Horenstein, Alberto; Vaisitti, Tiziana; Brusa, Davide; Davide, Rossi; Luca, Laurenti; Giovanni, D'Arena; Coscia, Marta; Claudio, Tripodo; Inghirami, Giorgio; Simon, Robson; Gianluca, Gaidano; Malavasi, Fabio; Deaglio, Silvia | |
| The PD-1/PD-L1 axis contributes to T cell dysfunction in chronic lymphocytic leukemia | 1-gen-2012 | Brusa, Davide; Serra, Sara; Bianco, M; Coscia, Marta; Rossi, D; Gaidano, G; Fedele, G; Deaglio, Silvia | |
| SELINEXOR (KPT-330) IN COMBINATION WITH CHEMOTHERAPY OR IDELALISIB ELICITS A SYNERGISTIC CYTOTOXIC EFFECT IN PRIMARY CLL CELLS, ALSO OVERCOMING INTRINSIC AND STROMAL CELLS-MEDIATED FLUDARABINE RESISTANCE | 1-gen-2018 | Todaro, M; Griggio, V; Vitale, C; Salvetti, C; Riganti, C; Boccadoro, M; Coscia, M | |
| AUTOIMMUNE HAEMOLYTIC ANAEMIA DURING BENDAMUSTINE PLUS RITUXIMAB TREATMENT IN CLL PATIENTS | 1-gen-2015 | Laurenti, L; Autore, F; Innocenti, I; D'Arena, G; Coscia, Marta; Mondello, P; Bellesi, S; Efremov, D; Sica, S; Mauro, Fr | |
| AUTOIMMUNE HAEMOLYTIC ANAEMIA DURING BENDAMUSTINE TREATMENT IN CLL PATIENTS | 1-gen-2015 | Autore, F; Innocenti, I; D'Arena, G; Coscia, Marta; Mondello, P; Pasquale, R; Sica, S; Laurenti, L. | |
| Chlorambucil PLUS Rituximab As FRONT-LINE Therapy for Elderly and/or Unfit CLL Patients. LONG-TERM Follow-up and Correlation with Biologic-Based Risk Stratification | 1-gen-2016 | Laurenti, L; Innocenti, I; Autore, F; Pasquale, R; Vannata, B; Ciolli, S; Mauro, Fr; Mannina, D; Del Poeta, G; D'Arena, G; Massaia, Massimo; Coscia, Marta; Molica, S; Pozzato, G; Efremov, Dg; Marasca, R; Galieni, P; Cuneo, A; Orlando, S; Piciocchi, A; Boncompagni, R; Vincelli, Di; Liberati, Am; Russo, F; Foa, R. | |
| Effective anti-tumor immunomodulatory properties of zoledronic acid | 1-gen-2007 | Coscia, Marta; Quaglino, Elena; Pantaleoni, Francesca; Curcio, C; Rigoni, MICOL MARIA; Forni, Guido; Massaia, Massimo | |
| Selinexor in Combination with Chemotherapy or Idelalisib Elicits a Synergistic Cytotoxic Effect in Primary CLL Cells, Also Overcoming Intrinsic and Stromal Cells-Mediated Fludarabine Resistance | 1-gen-2016 | Todaro, Maria; Griggio, Valentina; Vitale, Candida; Salvetti, Chiara; Riganti, Chiara; Boccadoro, Mario; Landesman, Y; Coscia, Marta | |
| CD200 INCLUDED IN A 4-MARKER MODIFIED MATUTES SCORE PROVIDES OPTIMAL SENSITIVITYAND SPECIFICITY FOR THE DIAGNOSIS OF CHRONIC LYMPHOCYTIC LEUKEMIA | 1-gen-2018 | D'Arena, G; Vitale, C; Rossi, G; Coscia, M; Omede, P; D'Auria, F; Statuto, T; Valvano, L; Ciolli, S; Gilestro, M; Molica, S; Bellesi, S; Topini, G; Panichi, V; Autore, F; Innocenti, I; Musto, P; Deaglio, S; Laurenti, L; Del Vecchio, L | |
| FIRST-LINE TREATMENT CHOICE FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: WHAT DO CLINICIANS CARE ABOUT? THE CLL FITNESS STUDY | 1-gen-2014 | Scarfo, L; Quaresmini, G; Ambrosetti, A; Laurenti, L; Rossini, F; Trentin, L; Coscia, Marta; Orlandi, E; Mannina, D; Torreggiani, A; Rambaldi, A; Semenzato, G; Innocenti, I; Brugiatelli, M; Cuneo, A; Foa, R; Molica, S; Morra, E; Pane, F; Pizzolo, G; Ghia, P. | |
| PROGRESSIVE TELOMERE SHORTENING DURING THE NATURAL HISTORY OF CHRONIC LYMPHOCYTIC LEUKEMIA | 1-gen-2011 | Genuardi, Elisa; Rossi, D; Bernocco, Elisa; Bodoni, Cl; Drandi, Daniela; Coscia, Marta; Ruggeri, Marina; Fangazio, M; Ghione, Paola; Gattei, V; Boccadoro, Mario; Omede', Pierluigi; Massaia, Massimo; Gaidano, G; Ladetto, Marco | |
| The Hypoxia-Inducible Factor-1 alpha Is Constitutively Upregulated in TP53 Disrupted CLL Cells: A Potential Target to Overcome Fludarabine Resistance | 1-gen-2015 | Griggio, Valentina; Vitale, Candida; Riganti, Chiara; Kopecka, Joanna; DAL BO', Moreno; Rossi, D; Pozzato, G; Laurenti, L; Zallio, F; Marchetti, M; Ruggeri, Marina; Omede', Pierluigi; Del Poeta, G; Gattei, V; Gaidano, G; Boccadoro, Mario; Massaia, Massimo; Coscia, Marta | |
| Outcome of Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) and/or 17p Deletion/TP53 Mutations Treated with Ibrutinib According to a Named Patient Program (NPP) in Italy: Preliminary Analysis of a Real Life Retrospective Study | 1-gen-2016 | Mauro, Fr; Tedeschi, A; Piciocchi, A; Motta, M; Iannella, E; Farina, L; Scarfo, L; Marasca, R; Coscia, Marta; Cortelezzi, A; Laurenti, L; Melpignano, A; Zinzani, Pl; Molica, S; Re, F; Andriani, A; Vincelli, Di; Visco, C; Gozzetti, A; Orlandi, Em; Trentin, L; Tani, M; Califano, C; Tagariello, G; Ghia, P; Caputo, Md; Salaroli, A; Innocenti, I; Frustaci, A; Vitale, Candida; Petulla, M; de Fabritiis, P; Vignetti, M; Fazi, P; Foa, R. | |
| EFFICACY AND SAFETY OF CHLORAMBUCIL PLUS RITUXIMAB AS FRONT-LINE THERAPY IN ELDERLY AND/OR UNFIT PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA. A GIMEMA RETROSPECTIVE STUDY | 1-gen-2015 | Laurenti, L; Autore, F; Innocenti, I; Vannata, B; Ciolli, S; Mauro, Fr; Mannina, D; Del Poeta, G; D'Arena, G; Massaia, Massimo; Coscia, Marta; Molica, S; Pozzato, G; Marasca, R; Galieni, P; Cuneo, A; Orlando, S; Piciocchi, A; Boncompagni, R; Vincelli, D; Liberati, Am; Russo, F; Foa, R. | |
| REGULATION OF HIF-1 alpha IN TP53 DISRUPTED CHRONIC LYMPHOCYTIC LEUKEMIA CELLS AND ITS POTENTIAL ROLE AS A THERAPEUTIC TARGET | 1-gen-2018 | Griggio, V; Vitale, C; Todaro, M; Riganti, C; Kopecka, J; Salvetti, C; Bomben, R; DAL BO', Moreno; Rossi, D; Pozzato, G; Marchetti, M; Omede, P; Bonello, L; Kodipad, Aa; Laurenti, GUIDO LUCA ALBINO; Del Poeta, G; Mauro, Fr; Bernardi, R; Gattei, V; Gaidano, G; Foa, R; Massaia, M; Boccadoro, M; Coscia, M | |
| Extracellular Nicotinamide Phosphoribosyltransferase (NAMPT) Shapes the CLL Microenvironment Promoting Macrophage M2 Polarization Via a Non-Enzymatic Mechanism | 1-gen-2014 | Audrito, Valentina; Serra, Sara; Brusa, Davide; Mazzola, F; Arruga, Francesca; Vaisitti, Tiziana; Coscia, Marta; Maffei, Riccardo; Rossi, D; Wang, T; Inghirami, G; Rizzi, M; Gaidano, G; Wolberger, C; Raffaelli, N; Deaglio, Silvia |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- Atti di Convegno479
- Articoli su Riviste1
Data di pubblicazione
- 2020 - 202562
- 2010 - 2019210
- 2000 - 2009139
- 1990 - 199959
- 1980 - 19899
- 1978 - 19791
Editore
- Bulzoni1
- Elsevier BV:PO Box 211, 1000 AE A...1
- Italian Association of Chemical E...1
- Lippincott, Williams & Wilkin...1
- Marine Biological Laboratory:7 MB...1
- Trans Tech Publications Limited:B...1
Rivista
- BLOOD16
- HAEMATOLOGICA16
- RIVISTA ITALIANA DI CHIRURGIA PLA...16
- JOURNAL OF PHYSICS. CONFERENCE SE...14
- LECTURE NOTES IN COMPUTER SCIENCE13
- GIORNALE ITALIANO DI MEDICINA DEL...12
- POS PROCEEDINGS OF SCIENCE11
- EPJ WEB OF CONFERENCES10
- ELECTRONIC NOTES IN THEORETICAL C...9
- MINERVA ANESTESIOLOGICA9
Serie
- CEUR WORKSHOP PROCEEDINGS11
- PROCEEDINGS OF SPIE, THE INTERNAT...9
- LECTURE NOTES IN ARTIFICIAL INTEL...6
- PROCEEDINGS OF THE ... ANNUAL CON...4
- WIT TRANSACTIONS ON ECOLOGY AND T...4
- CONTEMPORARY MATHEMATICS3
- IEEE ENGINEERING IN MEDICINE AND ...3
- CHEMICAL ENGINEERING TRANSACTIONS2
- IFIP ADVANCES IN INFORMATION AND ...2
- LECTURE NOTES IN COMPUTER SCIENCE2
Keyword
- Physics and Astronomy (all)13
- Condensed Matter Physics5
- Nuclear and High Energy Physics5
- and Optics4
- Atomic and Molecular Physics4
- Blockchain4
- Double beta decay4
- Materials Science (all)4
- Artifact-driven monitoring3
- Business process monitoring3
Lingua
- eng213
- ita55
- fre3
- und1
Accesso al fulltext
- no fulltext419
- reserved31
- open30